Taipei, April 24 (CNA) The mistaken publication by the World Health Organization (WHO) of results of a clinical trial on remdesivir, a potential therapy for COVID-19 patients, surprised Taiwan, but will not affect the separate trial in which it is participating.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Tests on deceased in Taipei food poisoning case finds Bongkrekic acid
03/28/2024 11:05 PM - Society
5 people remain in critical condition due to food poisoning in Taipei
03/28/2024 10:13 PM - Culture
Harvard Film Archive to hold event honoring Taiwan director Edward Yang
03/28/2024 09:52 PM - Sports
Turnout for CPBL pre-season games nearly triples
03/28/2024 09:31 PM - Society
Three staff members at food poisoning restaurant banned from leaving Taiwan
03/28/2024 09:12 PM